Avid Bioservices Inc (CDMO)

[biopharm]

Who is the Quartz Bio CEO and Founder from Sept 2012 - Oct 2017 ?
https://www.linkedin.com/in/jeromewojcik

....
Now he works for PMG along with Tobias Guennel...etc

Does everyone see the light? I hope so...because there is no way all these control arm issues occur and Peregrine playing musical chairs with Ronin Hedge Group it seems and do they even dare try a breadcrumbs deal ? I certainly hope not...because I see the light clearly

Berkeley Lights even and John R. Gunn 30 years at Memorial Sloan Kettering ?? We can't make this up ...of course Mr. Gunn has got to talk with Dr Jedd Wolchok.....one would assume.

https://www.berkeleylights.com/our-story/leadership/

How many non disclosed collaborations have existed that the new BODs are not aware about or maybe I should say how many have opportunities are being advanced in other areas or other companies that have had peeks into leaks of the platformitude (new word = astronomical amounts of data, generally Biomarker data, that is taken from one collaboration and used to profit another collaboration without expressed rights back to original IP owner) of information derived out of Peregrine Pharmaceuticals collaborations.

Has anyone wondered if the info matches up that was available to the old BOD vs the new....? FDA records can be summoned by the new BODs to make sure every piece of data the FDA has been provided is also provided to the new BODs....

This is all about proactive measures so the new BODs are not able to say "they did not know...a,b,c....to z" and any breadcrumbs deal must not be finalized till sharehders are provided with enough guarantees that fiduciary Duties are followed 100%

What is their rush anyhow to divest anything ....if it is true that the IP is not that worthy lol

Wake up and send in certified letters today, next day express

Make mention of many things in the last dozen posts because obviously, this is quiet time for the big deal or they are in on this staged act with what looks like some cover story to assist in the transfer of the IP